drugset
drugset / Trial / NCT01872754

Study Comparing the Use of Remifentanil Versus Propofol for Performing Bronchial Fibroscopy

NCT01872754 ↗

Phase 4 Completed 71 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether the use of Target-Controlled Infusion (TCI) of Remifentanil can deliver better conditions for performing bronchial fibroscopy with spontaneous ventilation (decrease the duration of cough) compared to the use of TCI of Propofol.

Timeline

Start
2013-07-31
Primary completion
2017-04-03
Completion
2017-04-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 2.5 ng/ml Intravenous
Subject Remifentanil Small molecule 4 ng/ml Intravenous

Indications

No indication recorded.